However, IL-6-mediated STAT3 activation has frequently been suggested to be a protective mechanism in chemotherapy-induced cell death through the increased expression of anti-apoptotic proteins such as Bcl-2 or survivin in solid tumors such as breast cancer and prostate cancer [33, 41, 42]. The gene discussed is BCL2; the disease is prostate carcinoma.